lysine-specific demethylase 5B inhibitors(OncoStatyx-Atomwise Joint Venture)

N/A

Report date: 2025/01/26 18:44:18
NME

Base Information

Drug Namelysine-specific demethylase 5B inhibitors(OncoStatyx-Atomwise Joint Venture)
Drug Alias NameKDM5B inhibitors(OncoStatyx-Atomwise Joint Venture)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 5B inhibitors
TargetsLysine-specific demethylase 5B
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoStatyx Llc
China Registration ClassN/A

Develop Information

Active CompaniesOncoStatyx Llc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A